92 related articles for article (PubMed ID: 11761966)
21. Evaluation of [Gd(Bz-TTDA)]2- as a potential contrast agent in MR imaging of the hepatobiliary system: an animal study.
Hsu JS; Jaw TS; Liu GC; Wang YM; Chen SH; Kuo YT; Jao JC; Li CW; Tsai KB
J Magn Reson Imaging; 2004 Oct; 20(4):632-9. PubMed ID: 15390149
[TBL] [Abstract][Full Text] [Related]
22. Intraindividual in vivo comparison of gadolinium contrast agents for pharmacokinetic analysis using dynamic contrast enhanced magnetic resonance imaging.
Liang J; Sammet S; Yang X; Jia G; Takayama Y; Knopp MV
Invest Radiol; 2010 May; 45(5):233-44. PubMed ID: 20351653
[TBL] [Abstract][Full Text] [Related]
23. Additional value of SPIO-enhanced MR imaging for the noninvasive imaging diagnosis of hepatocellular carcinoma in cirrhotic liver.
Yoo HJ; Lee JM; Lee JY; Kim SH; Kim SJ; Han JK; Choi BI
Invest Radiol; 2009 Dec; 44(12):800-7. PubMed ID: 19838119
[TBL] [Abstract][Full Text] [Related]
24. Liver vessel enhancement by Gd-BOPTA and Gd-EOB-DTPA: a comparison in healthy volunteers.
Brismar TB; Dahlstrom N; Edsborg N; Persson A; Smedby O; Albiin N
Acta Radiol; 2009 Sep; 50(7):709-15. PubMed ID: 19701821
[TBL] [Abstract][Full Text] [Related]
25. The efficacy of gadobenate dimeglumine (Gd-BOPTA) at 3 Tesla in brain magnetic resonance imaging: comparison to 1.5 Tesla and a standard gadolinium chelate using a rat brain tumor model.
Runge VM; Biswas J; Wintersperger BJ; Baumann SS; Jackson CB; Herborn CU; Patel T
Invest Radiol; 2006 Mar; 41(3):244-8. PubMed ID: 16481906
[TBL] [Abstract][Full Text] [Related]
26. Comparison of portal venous and delayed phases of gadolinium-enhanced magnetic resonance imaging study of cirrhotic liver for the detection of contrast washout of hypervascular hepatocellular carcinoma.
Cereser L; Furlan A; Bagatto D; Girometti R; Como G; Avellini C; Orsaria M; Zuiani C; Bazzocchi M
J Comput Assist Tomogr; 2010; 34(5):706-11. PubMed ID: 20861773
[TBL] [Abstract][Full Text] [Related]
27. Contrast-enhanced magnetic resonance cholangiography with Gd-BOPTA and Gd-EOB-DTPA in healthy subjects.
Dahlström N; Persson A; Albiin N; Smedby O; Brismar TB
Acta Radiol; 2007 May; 48(4):362-8. PubMed ID: 17453513
[TBL] [Abstract][Full Text] [Related]
28. Initial experience on utility of gadobenate dimeglumine (Gd-BOPTA) enhanced T1-weighted MR cholangiography in diagnosis of acute cholecystitis.
Akpinar E; Turkbey B; Karcaaltincaba M; Balli O; Akkapulu N; Balas S; Tirnaksiz B; Akata D; Akhan O
J Magn Reson Imaging; 2009 Sep; 30(3):578-85. PubMed ID: 19711404
[TBL] [Abstract][Full Text] [Related]
29. Relaxivity of Gadopentetate Dimeglumine (Magnevist), Gadobutrol (Gadovist), and Gadobenate Dimeglumine (MultiHance) in human blood plasma at 0.2, 1.5, and 3 Tesla.
Pintaske J; Martirosian P; Graf H; Erb G; Lodemann KP; Claussen CD; Schick F
Invest Radiol; 2006 Mar; 41(3):213-21. PubMed ID: 16481903
[TBL] [Abstract][Full Text] [Related]
30. Pulse repetition time and contrast enhancement: simulation study of Gd-BOPTA and conventional contrast agent at different field strengths.
Yrjänä SK; Vaara T; Karttunen A; Koivukangas J
Invest Radiol; 2008 Apr; 43(4):267-75. PubMed ID: 18340251
[TBL] [Abstract][Full Text] [Related]
31. Low-dose gadobenate dimeglumine versus standard-dose gadopentate dimeglumine for delayed contrast-enhanced cardiac magnetic resonance imaging.
Balci NC; Inan N; Anik Y; Erturk MS; Ural D; Demirci A
Acad Radiol; 2006 Jul; 13(7):833-9. PubMed ID: 16777557
[TBL] [Abstract][Full Text] [Related]
32. Gadobenate dimeglumine as a contrast agent for dynamic breast magnetic resonance imaging: effect of higher initial enhancement thresholds on diagnostic performance.
Sardanelli F; Fausto A; Esseridou A; Di Leo G; Kirchin MA
Invest Radiol; 2008 Apr; 43(4):236-42. PubMed ID: 18340247
[TBL] [Abstract][Full Text] [Related]
33. [Magnetic resonance tomography of the hepatobiliary system: indications, limitations and outlook].
Vogl TJ; Hammerstingl R; Schnell B; Eibl-Eibesfeldt B; Peqios W; Lissner J
Bildgebung; 1992 Dec; 59(4):195-9. PubMed ID: 1292771
[TBL] [Abstract][Full Text] [Related]
34. Liver Perfusion Modifies Gd-DTPA and Gd-BOPTA Hepatocyte Concentrations Through Transfer Clearances Across Sinusoidal Membranes.
Daire JL; Leporq B; Vilgrain V; Van Beers BE; Schmidt S; Pastor CM
Eur J Drug Metab Pharmacokinet; 2017 Aug; 42(4):657-667. PubMed ID: 27778300
[TBL] [Abstract][Full Text] [Related]
35. Gd-BOPTA transport into rat hepatocytes: pharmacokinetic analysis of dynamic magnetic resonance images using a hollow-fiber bioreactor.
Planchamp C; Gex-Fabry M; Dornier C; Quadri R; Reist M; Ivancevic MK; Vallée JP; Pochon S; Terrier F; Balant L; Stieger B; Meier PJ; Pastor CM
Invest Radiol; 2004 Aug; 39(8):506-15. PubMed ID: 15257212
[TBL] [Abstract][Full Text] [Related]
36. Quantification of Gd-BOPTA uptake and biliary excretion from dynamic magnetic resonance imaging in rat livers: model validation with 153Gd-BOPTA.
Planchamp C; Pastor CM; Balant L; Becker CD; Terrier F; Gex-Fabry M
Invest Radiol; 2005 Nov; 40(11):705-14. PubMed ID: 16230903
[TBL] [Abstract][Full Text] [Related]
37. Clinical utility and safety of MultiHance in magnetic resonance imaging of liver cancer: results of multicenter studies in Europe and the USA.
Hamm B; Kirchin M; Pirovano G; Spinazzi A
J Comput Assist Tomogr; 1999 Nov; 23 Suppl 1():S53-60. PubMed ID: 10608398
[TBL] [Abstract][Full Text] [Related]
38. Capsule of hepatocellular carcinoma: where and how does the capsule show enhancement?
Itai Y
Radiology; 1999 Feb; 210(2):577-9. PubMed ID: 10207449
[No Abstract] [Full Text] [Related]
39. How transfer rates generate Gd-BOPTA concentrations in rat liver compartments: implications for clinical liver imaging with hepatobiliary contrast agents.
Pastor CM
Contrast Media Mol Imaging; 2016 Jul; 11(4):291-8. PubMed ID: 27060676
[TBL] [Abstract][Full Text] [Related]
40. Comparison of Gd-BOPTA and Gd-DOTA for peripheral CE-MRA: a double-blind clinical study.
Lohr HA; Froehlich JM; Pfyffer M; Bader CW; Zollikofer CL; Wentz KU
Acad Radiol; 2002 Aug; 9 Suppl 2():S421-4. PubMed ID: 12188295
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
